Rating Change
B. Riley Securities analysts initiated coverage on 4D Molecular Therapeutics, Inc. Common Stock (NASDAQ:FDMT) with a Buy rating on July 31, 2026.
new coverageNASDAQ:FDMT
B. Riley Securities Initiates Coverage on 4D Molecular Therapeutics, Inc. Common Stock (FDMT) with Buy
Rating Change B. Riley Securities analysts initiated coverage on 4D Molecular Therapeutics, Inc. Common Stock (NASDAQ:FDMT) with a Buy rating on July 31, 2026.
Market Context
4D Molecular Therapeutics, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $10.18 with a market capitalization of $510.5M. The stock has gained 130.8% over the past 52 weeks.
Analyst coverage from B. Riley Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for 4D Molecular Therapeutics, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for 4D Molecular Therapeutics, Inc. Common Stock
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 31, 2026 | B. Riley Securities | Buy | N/A |
| Jul 20, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 20, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 19, 2026 | RBC Capital | Outperform | N/A |
| Mar 19, 2026 | Chardan Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View FDMT Stock Page
Frequently Asked Questions
What does a Buy rating mean for FDMT?
A Buy rating from B. Riley Securities reflects the analyst's outlook on 4D Molecular Therapeutics, Inc. Common Stock (NASDAQ:FDMT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the FDMT forecast page.